Skip to main content
Premium Trial:

Request an Annual Quote

Mary Jane Cunningham and Jim Sullivan


Mary Jane Cunningham, the former director of pharmacogenomics at Genometrix of the Woodlands, Texas, is the new director of discoveries at Molecular Mining in Kingston, Ontario. Cunningham developed a microarray-based gene expression database at Genometrix and previously worked at Incyte.

The company has also appointed Jim Sullivan as director of North American sales. Sullivan previously worked for Lion Biosciences as a Northeast US sales representative, as well as at Millipore, Tripos, and Genometrix.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.